Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Bevacizumab with Bortezomib in Relapsed/Refractory Multiple Myeloma
NCT00473590Phase 2Completed
- Sponsor
- Genentech
- Start
- Jun 2007
- Primary completion
- Nov 2009
- Modality
- Monoclonal Antibodies
01
Overview
A Phase 2 trial of bevacizumab in multiple myeloma (MM), sponsored by Genentech. Started Jun 2007; status: completed.
02
Drugs
bevacizumab
03
Conditions
multiple myeloma (MM)
Beyond the preview
Go deeper on NCT00473590.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00473590.